{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T23:02:25Z","timestamp":1708470145667},"reference-count":13,"publisher":"Wiley","issue":"s33","license":[{"start":{"date-parts":[[2008,12,30]],"date-time":"2008-12-30T00:00:00Z","timestamp":1230595200000},"content-version":"vor","delay-in-days":4322,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[1997,3]]},"abstract":"<jats:p>Subcutaneous specific immunotherapy has a considerable risk of side effects, including severe life\u2010threatening ones or even death. The disadvantages and problems of this kind of therapy gave rise to looking for new ways of hyposensitization. In allergic rhinitis the local (nasal) immunotherapy may be effective. We studied the efficacy of local nasal immunotherapy (Allerkin<jats:sup>R<\/jats:sup>) in grass and ragweed allergic children suffering from seasonal atopic rhinitis. Patients: 36 children (12 with grass pollen, 12 with ragweed pollen immunotherapy, 12 controls). Methods: nasal provocation tests with increasing doses of Allerkin, skin prick test, diary cards. Schedule of the investigations: enrollment of the patients and nasal provocation tests; grass pollen and ragweed pollen preseasonal immunotherapy with increasing doses of Allerkiq during pollen season registration of symptoms and drug consumption; after the season nasal provocation tests. Results: grass immunotherapy: nasal provocation threshold increased (P&lt;0.Ol), symptoms became fewer (P&lt;0.Ol) and drug consumption was less in the active group compared to control. Similar but less expressed tendencies were seen in the ragweed group. After the second year of immunotherapy the need for steroid treatment was significantly (P&lt;0.05) fewer in the immunotherapy group than in the control group. No side effects appeared during the course of immunotherapy, but some patients suffered from mild sneezing or nasal discharge after the Allerkin application. Conclusion: local (nasal) immunotherapy is an effective, safe and not troublesome alternative to systemic immunotherapy.<\/jats:p>","DOI":"10.1111\/j.1398-9995.1997.tb04805.x","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T22:43:59Z","timestamp":1230763439000},"page":"40-44","source":"Crossref","is-referenced-by-count":8,"title":["Nasal immunotherapy in pollen\u2010sensitive children"],"prefix":"10.1111","volume":"52","author":[{"given":"E.","family":"Cserh\u00e1ti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mezei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,30]]},"reference":[{"key":"e_1_2_1_2_2","unstructured":"BousquetJ MichelFB.Sub\u2010cutaneous and local specific immunotherapy in perspective. In:BasombaA SastreJ editors. XVI European Congress of Allergology and Clinical Immunology Madrid 1995.Proceedings I. Monduzzi Bologna 1995:717\u201322."},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1977.tb01357.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(81)90067-1"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(83)90461-X"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(83)90549-3"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(93)90211-W"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1995.tb01019.x"},{"key":"e_1_2_1_9_2","unstructured":"JacobsenL.The benefit of specific allergy treatment. In:BasombaA SastreJ editors. XVI European Congress of Allergology and Clinical Immunology Madrid 1995.Proceedings I. Monduzzi Bologna 1995:745\u201350."},{"key":"e_1_2_1_10_2","first-page":"76","volume-title":"Global initiative for asthma","author":"NHLBI\/WHO Workshop Report","year":"1995"},{"key":"e_1_2_1_11_2","first-page":"277","article-title":"Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A doubleL blind study","volume":"18","author":"Tari MG","year":"1990","journal-title":"Allergol Immunopathol Madr"},{"key":"e_1_2_1_12_2","first-page":"542","article-title":"Oral immunotherapy of adults with allergic rhinoconjunctivitis","volume":"39","author":"Taudorf E.","year":"1992","journal-title":"Clinical effects in birch and grass pollinosis Dan Med Bull"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(93)90166-D"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1994.tb00917.x"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.1997.tb04805.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.1997.tb04805.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T21:49:53Z","timestamp":1695764993000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.1997.tb04805.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3]]},"references-count":13,"journal-issue":{"issue":"s33","published-print":{"date-parts":[[1997,3]]}},"alternative-id":["10.1111\/j.1398-9995.1997.tb04805.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.1997.tb04805.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,3]]}}}